2013, Number 3
<< Back Next >>
Rev Cubana Hematol Inmunol Hemoter 2013; 29 (3)
Progressive hemifacial atrophy or Parry Romberg Syndrome associated with immunodeficiency
Sánchez SMC, Marsán SV, Macías AC, García GA, Valcárcel LJ, del Valle PLO, Socarrás FB, Arce HAA
Language: Spanish
References: 29
Page:
PDF size: 93.91 Kb.
ABSTRACT
The progressive hemifacial atrophy (AHP) or Parry Romberg syndrome, is a rare
degenerative disease, characterized by slowly progressive unilateral facial atrophy
involving the subcutaneous tissue, cartilage, fat tissue and underlying bone structures,
which often overlaps with a condition known as linear scleroderma «en coup of sabre».
To our knowledge has not been reported the association between immunodeficiency
and this syndrome. We report the case of a child of 5 years with AHP, with a history of
recurrent infectious processes, some serious, since he was 7 months old. The
immunological study showed T cell immunodeficiency, lymphocyte subpopulations
showed T/CD4 T/CD3 + cells values decreased and normal value B/CD19 + cells. The
presence of antinuclear homogeneous pattern and anti-dsDNA antibodies confirm de
autoimmune disorders described in these patients. The cellular immunodeficiency with
AHP is an expression of great clinical variability of this disease and the importance of
early diagnosis.
REFERENCES
Grimaldi M, Gentile P, Labardi L, Silvi E, Trimarco A, Cervelli V. Lipostructure technique in Romberg syndrome. J Craniofac Surg 2008 Jul;19(4):1089-91.
Kacinski M, Biedron A, Zajac A, Steczkowska M. Diagnostic difficulties of paroxysmal symptoms in a boy with Parry Romberg syndrome. Neurol Neurochir Pol 2010 May- Jun;44(3):297-303.
Maletic J, Tsirka V, Ioannides P, Karacostas D, Taskos N. Parry-Romberg Síndrome with Localizad Scleroderma. Case Rep Neurol 2010 Jun; 2(2):57-62.
WójcickiP, Zachara M. Surgical treatment of patients with Parry Romberg syndrome. Ann Plast Surg 2011 Mar;66(3):267-72.
Wikipedia. Parry-romberg syndrome. Disponible en: http//pillen.wikipedia.wikipedia.org/wiki/Parry%E2%80%93Romberg-syndrome (Visitada 18-8-11, actualizada 22-9-11)
Stone J. Parry Romberg síndrome. Practical Neurology 2006 August 22; 6(3):185-8.
Buonanotte F. Síndrome de Parry Romberg: variaciones clínicas y consideraciones neurológicas. Rev Neurol 2007 Jul; 45(3):189-90.
Kakisaka Y, So NK, Jones S, Wang ZI, Mosher JC, Alexopoulos AV et al. Intractable focal epilepsy contralateral to the side of facial atrophy in Parry-Romberg syndrome. Neurol Sci 2011 Feb;33(1):165-8. DOI 10.1007/s10072-11-0643-z.
Viana M, Glastonbury CM, Sprenger T, Goadsby PJ. Trigeminal neuropathic pain in a patient with progressive facial hemiatrophy (parry-romberg syndrome). Arch Neurol 2011 Jul;68(7):938-43.
Nasser O, Greiner K, Amer R. Unilateral optic atrophy preceding Coats Disease in a girl with Parry-Romberg syndrome. Eur J Ophthalmol 2010 Jan-Feb;20(1):221-3.
Zubcov-Iwantscheff AA, Thomke F, Goebel HH, Bacharach-BuhlesM, Cordey A, Constantinescu CS et al. Eye movement involvement in Parry-Romberg Syndrome: a clinicopathologic case report. Strabismus 2008 Jul-Sep;16(3):119-21.
Dawczynski J, Thorwarth M, Koenigsdoerffer E, Schultze-Mosgau S. Interdisciplinary treatment and ophthalmological findings in Parry-Romberg syndrome. J Craniofac Surg 2006 Nov;17(6):1175-6.
Chiang KL, Chang KP, ong TT, Hsu TR. Linear scleroderma «en coup de sabre»: inicial presentation as intractable partial seizures in a child. Pediatr Neonatol 2009 Dec;50(6):294-8.
Vaienti L, soresina M, Menozzi A. Parascapular free flat and fat grafts: Combined surgical methods in morphological restoration of hemifacial Progressive atrophy. Plast Reconst Surg 2005 Sept;116(3):699-711.
Ye XD, Li CY, Wang C, Yu YS. Superficial temporal fascial flap plus lipofilling for facial contour reconstruction in bilateral progressive facial hemiatrophy. Aesthetic Plast Sur 2010 Aug;34(4):537-7.
Duymaz A, Karabekmez FE, Keskin M, Tosun Z. Parry-Romberg syndrome: facial atrophy and its relationship with other regions of the body. Ann Plast Surg 2009 Oct;63(4):457-61.
Ruhin B, Bennaceur S, Vercke F, Louafi S, Seddiki B, Ferri J. Progressive hemifacial atrophy in the young patient: phisiopathologic hypotheses, diagnosis and therapy. Rev Stomatol Chir Maxillofac 2010 Dec;101(6):287-97.
Pinheiro TP, Silva CC, Silveira CS, Botelho PC, Pinheiro MG, Pinheiro Jde J. Progressive Hemifacial Atrophycase report. Med Oral Patol Oral Cir Bucal 2006 March 1;11(2):E112-4.
Okumura A, Ikuta T, Tsuji T, Fujatsu H, Naganawa S, Kato K, et al. Parry-Romberg syndrome with a clinically silent white matter lesion. AJNR Am J Neuroradiol 2006 Sept;27(8):1729-31.
Thapa R, Ghosh A, Dhar S. Parry-Romberg Syndrome with Band-like Alopecia. Indian J Pediat 2009 Jul;76(s/n):760.
Gulati S, Jain V, Garg G. Parry Romberg Syndrome. Indian J Pediat 2006 May;73(s/n):448-9.
Galarza C, Gutiérrez E, Ramos W, Macetas R, Mendoza M, Gómez A, et al. Síndrome de Parry Romberg. Dermatol Peru 2006;16(2):151-4.
Mizraji G, Yacovino D, Sinay V, De simone V, Kadar J, Chade A, et al. Síndrome de Parry Romberg. Rev Neurol Argentina 2001 Nov; 26:78-82.
Ren M, Teng L, Gui L. Clinical study on correction of hemifacial atrophy with free anterolateral thigh adipofascial flap. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2007 Sop;21(9):913-6.
Kumar AA, Kumar RA, Shantha GP, Aloogopinathan G. Progressive hemifacial atrophy Parry Romberg syndrome presenting as severe facial pain in a young man: a case report. Cases J 2009 Jul 2;6776.
Lane T, Cheung J, Schaffer J. Parry-Romberg syndrome with coexistent morphea. Dermatology Online Journal 2008 Oct;14(10):21-22.
Abbas K, Lichtman A, Pober J. Mecanismos efectores de la inmunidad Celular. En: Inmunología celular y molecular.4 ed. Madrid. McGraw-Hill. Interamericana; 2002.p.303-21.
Marsán V, Villaescusa R, del Valle LO, Arce A, Torres I, Macías C. Inmunodeficiencia primaria combinada: Presentación de un caso. Rev Cubana Hematol Inmunol Hemoter 2001 ene-abr;17(1):55-8.
Barboza L, Martens ML, Salmen S, Peterson DL, Montes H, Berruela L. Déficit en señales de activación y coestimulación en linfocitos T CD4+ de pacientes infectados con el virus de la hepatitis C. Invest Clin 2008 Feb;49(3):353-67.